期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Research on the Regulatory Framework of Advanced Therapies in the European Union and the United States
1
作者 Wulan Qiqige Yang Yue Huang Zhe 《Asian Journal of Social Pharmacy》 2023年第2期98-106,共9页
Objective To study the regulatory framework of advanced therapies in the European Union and the United States,and to provide reference for the regulation of cell-and gene-based therapeutic products in China.Methods Th... Objective To study the regulatory framework of advanced therapies in the European Union and the United States,and to provide reference for the regulation of cell-and gene-based therapeutic products in China.Methods The legal and regulatory documents,annual reports,work information and related literature published on the websites of the FDA and European Medicines Agency(EMA)were reviewed to analyze the regulatory models of advanced therapies in the European Union and the United States.Results and Conclusion the United States and the European Union have carried out a lot of work in the classification standards of advanced therapies,policy formulation and accelerated listing procedures.Therefore,they have established a relatively mature regulatory system.China can learn from their experience and continuously improve the regulatory system to help the sustainable development of gene and cell therapy industry. 展开更多
关键词 advanced therapy gene therapy product cell therapy product European Union USA
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部